Voloridge Investment Management
EVH icon

Voloridge Investment Management’s Evolent Health EVH Stock Holding History

Voloridge Investment Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-142,307
Closed -$4.6M – 1486
2022
Q1 		$4.6M Sell
142,307
-26,256
-16% -$687K 0.03% 663
2021
Q4 		$4.66M Buy
+168,563
New +$4.84M 0.03% 753
2021
Q3 		– Sell
-46,417
Closed -$980K – 1707
2021
Q2 		$980K Sell
46,417
-65,656
-59% -$1.32M 0.01% 1259
2021
Q1 		$2.26M Sell
112,073
-77,944
-41% -$1.48M 0.02% 784
2020
Q4 		$3.05M Sell
190,017
-153,858
-45% -$2.03M 0.03% 599
2020
Q3 		$4.27M Sell
343,875
-69,963
-17% -$823K 0.04% 488
2020
Q2 		$2.95M Buy
413,838
+373,596
+928% +$2.5M 0.03% 502
2020
Q1 		$219K Buy
+40,242
New +$359K 0.01% 933
2019
Q4 		– Sell
-137,247
Closed -$987K – 1162
2019
Q3 		$987K Buy
137,247
+15,190
+12% +$109K 0.02% 644
2019
Q2 		$970K Buy
122,057
+38,232
+46% +$453K 0.03% 462
2019
Q1 		$1.05M Buy
+83,825
New +$1.33M 0.03% 455

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Voloridge Investment Management's EVH Position: Q2 2022 in Review

Voloridge Investment Management sold out of Evolent Health (EVH) in Q2 2022, closing a stake of 142,307 shares — an estimated $4.6M sold.

Voloridge Investment Management first reported a position in EVH in Q1 2019 and held it in 11 quarters. The position peaked at $4.66M in Q4 2021. 215 funds tracked by Wall St. Rank hold EVH as of Q2 2022.

  • Voloridge Investment Management reported no remaining Evolent Health position as of Q2 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 142,307 Evolent Health shares in Q2 2022, an estimated $4.6M.
  • Voloridge Investment Management first reported a position in Evolent Health in Q1 2019 and held it in 11 quarters.
  • Voloridge Investment Management's Evolent Health position peaked at $4.66M in Q4 2021.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q2 2022.

Based on Voloridge Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.